Clinical value of drug-coated balloon versus second-generation drug-eluting stent for de novo lesions in large coronary arteries: insights from the real world
DCB-only strategy is feasible for LCA de novo lesions in patients with high bleeding risk, but not suitable in other patients, who should first choose intended stenting strategy especially with unmanageable hypercholesteremia, severe calcified lesions or non-ideal residual stenosis after preprocessing.
Authors
- Kang Zhao (ORCID: https://orcid.org/0000-0002-5732-858X)
- Muwei Li (ORCID: https://orcid.org/0009-0000-7550-5415)
- Lixin Rao (ORCID: https://orcid.org/0009-0002-6654-4062)
- Quan Guo (ORCID: https://orcid.org/0000-0002-8833-0383)
- Liang Peng (ORCID: https://orcid.org/0000-0001-7021-4651)
- Haiyu Tang
- Zhao Zhenzhou (ORCID: https://orcid.org/0000-0003-3729-0032)
- Ran You
Institutions
- Zhengzhou University (CN)
- Henan Provincial People's Hospital (CN)
- Zhengzhou Central Hospital (CN)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1186/s12872-024-04386-w
- Citations
- 7
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 4.01